Comparison of effectiveness between polaprezinc and Zinc acetate hydrate on hypozincemia in hemodialysis patients.
Not Applicable
- Conditions
- Zinc deficiency
- Registration Number
- JPRN-UMIN000038759
- Lead Sponsor
- Kenwakai Hospital hemodialysis center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patient after enterectomy Patients with peritoneal dialysis Pregnant or breastfeeding Patients allergic to zinc acetate hydrate or polaprezinc Patients who are unable to carry out contraindications or contraception during the study period Patients who are difficult to take orally Patients with serum copper less than 30microg/dL Patients judged to be inappropriate for inclusion in the study by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method